scholarly article | Q13442814 |
P2093 | author name string | David A Mann | |
Dihui Hong | |||
Jayne Hesley | |||
Oksana Sirenko | |||
Coby B Carlson | |||
Michael K Hancock | |||
Avrum Cohen | |||
Jason Gentry | |||
P2860 | cites work | PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma | Q39796127 |
3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis | Q46711797 | ||
Bridging in vitro and in vivo metabolism and transport of faldaprevir in human using a novel cocultured human hepatocyte system, HepatoPac. | Q46889202 | ||
Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans | Q46960278 | ||
Vascularized and functional human liver from an iPSC-derived organ bud transplant | Q48453997 | ||
Human induced pluripotent stem cell-derived hepatocytes for toxicology testing | Q48716931 | ||
Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. | Q50693981 | ||
3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions. | Q52879768 | ||
Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing | Q57142913 | ||
The Use of Hepatocytes to Investigate Drug Toxicity | Q58680907 | ||
3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells | Q83346462 | ||
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation | Q30514021 | ||
MitoTracker Green labeling of mitochondrial proteins and their subsequent analysis by capillary electrophoresis with laser-induced fluorescence detection | Q31150745 | ||
High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening | Q33239100 | ||
Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds | Q33246667 | ||
High throughput quantification of mutant huntingtin aggregates | Q33325820 | ||
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array | Q34145183 | ||
Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain | Q34212006 | ||
Microscale technologies for tissue engineering and biology | Q34479429 | ||
Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. | Q34561432 | ||
Multi-cell type human liver microtissues for hepatotoxicity testing | Q34645248 | ||
In vitro models to study hepatotoxicity. | Q34672524 | ||
Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. | Q34812924 | ||
An HTS-compatible 3D colony formation assay to identify tumor-specific chemotherapeutics | Q34897995 | ||
Toxicology for the twenty-first century | Q34991369 | ||
High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells | Q35042726 | ||
Designing materials for biology and medicine | Q35730863 | ||
High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures | Q35759165 | ||
The use of 3-D cultures for high-throughput screening: the multicellular spheroid model | Q35801815 | ||
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins | Q35828228 | ||
High-throughput imaging: Focusing in on drug discovery in 3D. | Q35853192 | ||
Opportunities for use of human iPS cells in predictive toxicology | Q36672246 | ||
Phenotypic screens targeting neurodegenerative diseases | Q38130052 | ||
Perfused multiwell plate for 3D liver tissue engineering | Q38590052 | ||
Engineering EMT using 3D micro-scaffold to promote hepatic functions for drug hepatotoxicity evaluation. | Q38784859 | ||
Enhanced Metabolizing Activity of Human ES Cell-Derived Hepatocytes Using a 3D Culture System with Repeated Exposures to Xenobiotics | Q38862327 | ||
Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro | Q39094576 | ||
Developing high-fidelity hepatotoxicity models from pluripotent stem cells | Q39140743 | ||
Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening | Q39290618 | ||
Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues | Q39439698 | ||
Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells. | Q39562856 | ||
P433 | issue | 7 | |
P304 | page(s) | 381-394 | |
P577 | publication date | 2016-08-05 | |
P1433 | published in | Assay and Drug Development Technologies | Q15767279 |
P1476 | title | Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis | |
P478 | volume | 14 |
Q58697388 | A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis |
Q90732443 | Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury |
Q50099283 | High-Content Monitoring of Drug Effects in a 3D Spheroid Model |
Q51418353 | High-content imaging assays on a miniaturized 3D cell culture platform. |
Q50300835 | Leukocyte count of puerperal sows |
Q57171910 | Machine learning and image-based profiling in drug discovery |
Q48464143 | Neural organoids for disease phenotyping, drug screening and developmental biology studies |
Q52684315 | Novel 3D Liquid Cell Culture Method for Anchorage-independent Cell Growth, Cell Imaging and Automated Drug Screening. |
Q46310313 | Organoid technology for brain and therapeutics research |
Q60926717 | Recapitulation of methotrexate hepatotoxicity with induced pluripotent stem cell-derived hepatocytes from patients with rheumatoid arthritis |
Q65002709 | Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. |
Q92728096 | Use of stem cells as alternative methods to animal experimentation in predictive toxicology |
Q99726012 | Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models |
Q91712113 | iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery |
Search more.